MA-RENAGADE-THERAPEUTICS
22.4.2024 22:47:33 CEST | Business Wire | Press release
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced an oral and poster presentation highlighting preclinical data supporting its comprehensive RNA technology platform at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting being held May 7-11, 2024, in Baltimore, Maryland.
“We are excited to highlight foundational research and development advancements at ASGCT supported by our poster presentation illuminating ReNAgade’s continued work in validating our immune tropic LNP-based delivery systems in NHPs with broad potential applications in oncology and autoimmune diseases,” said Pete Smith, Ph.D., Chief Scientific Officer of ReNAgade. “Additionally, our oral presentation demonstrates a non-viral, all-RNA gene editing system enabling in vivo, exon-sized insertion and probable re-dosing with the goal of higher specificity and a better safety profile when used in the clinical setting. Together, these promising data are another important step in our efforts to innovate beyond the current limitations of RNA medicine.”
Key Highlights from the Abstracts:
- Employed a systematic barcoding screening approach to evaluate and identify engineered lipid nanoparticles (LNP) from a library of 200+ LNPs across multiple structural and chemically distinct classes of ionizable, helper, structural, and hydrophilic lipids. Lead LNP candidate demonstrated ~60% delivery efficiency in total splenic T cells and ~80% delivery efficiency in peripheral blood T cells in non-human primate models.
- Improved retron-mediated target insertion through a combination of retron reverse transcriptase (RT) engineering, non-coding RNA (ncRNA) minimization, chemical modification, and homology-dependent repair manipulation. Combination of retron system optimization and ncRNA engineering led to 2-fold higher 305 base pair insertion and ~40% editing efficiency in hematopoietic stem cells.
ASGCT Annual Meeting Presentation Details:
- TITLE: “Retron Mediated Exon-Sized Genome Insertion Using an All-RNA System”
SESSION TITLE: New Technologies for Gene Targeting and Gene Correction
PRESENTATION TYPE: Oral
ABSTRACT NUMBER: 14
PRESENTER: Inna Shcherbakova, Ph.D., Senior Director, Platform, ReNAgade Therapeutics
DATE AND TIME: Tuesday, May 7, 2024, from 2:15 p.m. - 3:30 p.m. ET
- TITLE: “Novel Immune Tropic LNP-Based mRNA Delivery in Non-Human Primates”
SESSION TITLE: Wednesday Posters: Other Nonviral Delivery
PRESENTATION TYPE: Poster
ABSTRACT NUMBER: 749
PRESENTER: Juliet Crabtree, Ph.D., Associate Principal Scientist, ReNAgade Therapeutics
DATE AND TIME: Wednesday, May 8, 2024, at 12:00 p.m. ET
About ReNAgade Therapeutics
ReNAgade exists to unlock the potential for RNA medicines to treat disease anywhere in the body. We combine our novel RNA delivery platforms with a comprehensive RNA platform allowing for an all-RNA system for coding, editing, and gene insertion to develop new medicines.
To accelerate the future of medicine, we bring together a team with deep RNA and delivery expertise to develop paradigm-shifting RNA medicines.
ReNAgade Therapeutics—RNA Without Limits
For more information about the company, its technologies, and its leadership, visit www.renagadetx.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240422868550/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NIQ Expands Google Relationship with Meridian Integration into NIQ Cadence™30.9.2026 12:30:00 CEST | Press release
Meridian, Google’s open-source Marketing Mix Modeling (MMM), is now available within NIQ Cadence™, accelerating the path from measurement to continuous marketing optimization in one connected workflow. NIQ (NYSE: NIQ), a leading consumer intelligence company, today announced the expansion of its relationship with Google through the integration of Meridian, Google's open-source MMM framework, into NIQ Cadence™, NIQ's AI-native marketing effectiveness operating system. The strategic partnership gives marketers a single place to measure marketing performance and act on it, shortening the distance between insights and optimization. Marketing leaders are under growing pressure to prove the return on every media dollar, and traditional measurement has struggled to keep pace. In NIQ’s latest CMO Report, 74% of CMOs said they were under more scrutiny to prove marketing ROI, while just 9% felt they had adequate access to real-time insights. NIQ Cadence™ was built to help close the 65-point acti
Compass Pathways Appoints Kelley Boucher as Chief People Officer30.9.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced the appointment of Kelley Boucher as Chief People Officer, effective today. This appointment strengthens the Compass executive team as the company continues to scale in support of its mission to bring the first classic psychedelic treatment to the field of psychiatry. In this role, Ms. Boucher will oversee the Company’s people strategy, with an initial focus on guiding its planned evolution towards the launch of COMP360 psilocybin, subject to FDA approval, in the first half of 2027. "We are thrilled to welcome Kelley to our executive team at this pivotal moment in Compass’ journey. As we prepare for our NDA submission in the fourth quarter of this year, we are closer than ever to achieving our goal of introducing an entirely new treatment model in mental health care with COMP360 psilocybin," said Kabir Nath, Chief Executive Officer a
EUMETSAT: Media Invitation30.9.2026 12:17:00 CEST | Press release
Weather in 4D Every 30 Minutes: Europe’s First Geostationary Infrared Sounder Enters Operational Service For the first time, weather forecasters will have access to near-real-time, four-dimensional observations of the atmosphere over Europe every 30 minutes from Europe’s first meteorological infrared sounder in geostationary orbit. EUMETSAT invites media to mark this milestone as the Infrared Sounder (IRS) on board MTG-S1 enters operational service. To mark the occasion, MTG-S1 will also take the name Meteosat-13. The event will showcase the first operational IRS data and EUMETSAT’s 4D weather cube, which combines observations of atmospheric profiles, winds, convection and lightning from three key MTG instruments. Before MTG, only weather models could provide this complete view; now it can be built from real observations and updated every 30 minutes. Journalists will have the opportunity to discover the new data and hear how they can support weather forecasting and the monitoring of ra
Sitetracker Selected by BNZ to Support Scalable Multitechnology Renewable Energy Growth Across Southern Europe30.9.2026 12:07:00 CEST | Press release
Sitetracker, the global leader in complete Asset Lifecycle Management for critical infrastructure, today announced that BNZ, an independent power producer (IPP) focused on renewable energy across Southern Europe, has selected Sitetracker to streamline and scale the management of its growing multitechnology portfolio. BNZ develops, builds, and operates utility-scale renewable energy assets across Spain, Italy, and Portugal. Its portfolio exceeds 2.7 GW across development, construction, and operation, including 530 MW connected and 222 MW under construction. To support its continued growth, BNZ sought a centralized platform to improve visibility, standardize workflows, and strengthen operational efficiency across the full asset lifecycle. “The next generation of renewable energy leaders will be defined by how efficiently they can scale,” said Giuseppe Incitti, CEO of Sitetracker. “BNZ is taking a proactive approach to building the operational infrastructure needed to support long-term gr
Linesight Appoints John Butler as CEO30.9.2026 12:00:00 CEST | Press release
Paul Boylan continues to lead the wider IPS group as CEO Linesight, the global construction consultancy, today announced the appointment of John Butler as Chief Executive Officer, effective 1 January 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260930482486/en/ John Butler, incoming CEO of Linesight (left), and Paul Boylan, Group CEO of IPS-Integrated Project Services, LLC (right). Butler will become CEO of Linesight effective 1 January 2027, succeeding Boylan, who will continue to lead the wider group. Butler will succeed Paul Boylan, who will remain closely involved with Linesight and its clients as Group CEO of IPS-Integrated Project Services, LLC (IPS). Boylan will continue to lead this wider group, encompassing IPS, Linesight and Springtide. Today, the group comprises of more than 4,500 people and generates approximately $2 billion in net revenue, providing multi-sector solutions through its specialist brands. L
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom